Target intelligence / Profile preview

EXO5 divergent transcript (EXO5-DT)

Target: EXO5-DT
Molecular classification: Other, Putative long non-coding RNA, Divergent transcript

Overview

EXO5 divergent transcript" (EXO5-DT) refers to a putative RNA molecule transcribed from the EXO5 gene locus, likely in the opposite direction (antisense or divergent promoter context)[4]. There is currently no scientific evidence that this transcript encodes a protein or acts as a therapeutic target. Most research and databases only describe the EXO5 protein, a single-stranded DNA exonuclease involved in DNA repair and cancer risk, but not the divergent transcript itself[1][2][3]. There is no documentation of EXO5-DT in drug targeting, biomarker applications, or molecular mechanisms. The biological role, if any, is unknown.

Biological functions

OtherPotential regulatory function

Disease associations

OtherNo direct evidence

Beyond the preview

Go deeper on EXO5 divergent transcript (EXO5-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EXO5 divergent transcript (EXO5-DT).

Explore the full profile